Clinical Trials for CAR T Cells at Bezos Family Immunotherapy Clinic
David G. Maloney, MD, PhD, medical director of immunotherapy at the Seattle Cancer Care Alliance and member of Fred Hutchinson Research Center, discusses the clinical trials that are currently investigating chimeric antigen receptor T cells at the Bezos Family Immunotherapy Clinic at Fred Hutchinson.
David G. Maloney, MD, PhD, medical director of immunotherapy at the Seattle Cancer Care Alliance and member of Fred Hutchinson Research Center, discusses the clinical trials that are currently investigating chimeric antigen receptor (CAR) T cells at the Bezos Family Immunotherapy Clinic at Fred Hutchinson.
There are 18 different clinical trials actively looking at CAR T cells in a variety of settings. In breast and lung cancers, Maloney says they are testing CAR T cells against ROR1, which is exciting. In multiple myeloma, multiple companies are involved in BCMA CAR T cells trials.
Survivorship Care Promotes Evidence-Based Approaches for Quality of Life and Beyond
March 21st 2025Frank J. Penedo, PhD, explains the challenges of survivorship care for patients with cancer and how he implements programs to support patients’ emotional, physical, and practical needs.
Read More
